New Alzheimer’s drug slows progression, but not cure
Dr. Keith Roach Dear Dr. Roach:The U.S. Food and Drug Administration has granted traditional approval to Leqembi (lecanemab) for the treatment of early-onset Alzheimer’s disease. Although it is not yet a cure, it appears to slow the progression of symptoms. Since treatment must be started early in the course of the disease, should older people …